Hagit Eldar-Finkelman

Prof. Hagit Eldar-Finkelman - Tel Aviv University - (August 2021) Hagit Eldar-Finkelman () is an Israeli scientist and a principal investigator of an active research laboratory at the Sackler School of Medicine at Tel Aviv University. Eldar-Finkelman’s research is focused on the signal transduction field and drug development targeting protein kinases. She is well known for her pioneering work on the functions of GSK-3 and its contribution to diabetes and other pathogenies, including depressive behavior, Alzheimer’s diseases, and Huntington’s diseases. Novel findings also include the unique evolution of GSK-3 isozymes. Eldar-Finkelman is a leading figure in developing novel substrate competitive inhibitors (SCIs) for GSK-3 with significant benefits as drug candidates. Provided by Wikipedia
Showing 1 - 8 results of 8 for search 'Hagit Eldar-Finkelman', query time: 0.03s Refine Results
  1. 1
    Mechanisms and Therapeutic Implications of GSK-3 in Treating Neurodegeneration

    Mechanisms and Therapeutic Implications of GSK-3 in Treating Neurodegeneration by Ido Rippin, Hagit Eldar-Finkelman

    Published 2021-01-01
    Get full text
    Article
  2. 2
    Glycogen Synthase Kinase-3 Inhibitors: Preclinical and Clinical Focus on CNS-A Decade Onward

    Glycogen Synthase Kinase-3 Inhibitors: Preclinical and Clinical Focus on CNS-A Decade Onward by Sara Melisa Arciniegas Ruiz, Hagit Eldar-Finkelman

    Published 2022-01-01
    Get full text
    Article
  3. 3
    Prospects in GSK-3 Signaling: From Cellular Regulation to Disease Therapy

    Prospects in GSK-3 Signaling: From Cellular Regulation to Disease Therapy by Sara Arciniegas Ruiz, Ido Rippin, Hagit Eldar-Finkelman

    Published 2022-05-01
    Get full text
    Article
  4. 4
    GSK-3β Inhibition in Birds Affects Social Behavior and Increases Motor Activity

    GSK-3β Inhibition in Birds Affects Social Behavior and Increases Motor Activity by Stan Moaraf, Ido Rippin, Joseph Terkel, Hagit Eldar-Finkelman, Anat Barnea

    Published 2022-04-01
    Get full text
    Article
  5. 5
    Nonsense mutation suppression is enhanced by targeting different stages of the protein synthesis process.

    Nonsense mutation suppression is enhanced by targeting different stages of the protein synthesis process. by Amnon Wittenstein, Michal Caspi, Ido Rippin, Orna Elroy-Stein, Hagit Eldar-Finkelman, Sven Thoms, Rina Rosin-Arbesfeld

    Published 2023-11-01
    Get full text
    Article
  6. 6
    Small molecule modulation of p75NTR engages the autophagy-lysosomal pathway and reduces huntingtin aggregates in cellular and mouse models of Huntington's disease

    Small molecule modulation of p75NTR engages the autophagy-lysosomal pathway and reduces huntingtin aggregates in cellular and mouse models of Huntington's disease by Danielle A. Simmons, Namitha Alexander, Gloria Cao, Ido Rippin, Yarine Lugassy, Hagit Eldar-Finkelman, Frank M. Longo

    Published 2025-03-01
    Get full text
    Article
  7. 7
    Physiological expression of mutated TAU impaired astrocyte activity and exacerbates β-amyloid pathology in 5xFAD mice

    Physiological expression of mutated TAU impaired astrocyte activity and exacerbates β-amyloid pathology in 5xFAD mice by Dorit Farfara, Meital Sooliman, Limor Avrahami, Tabitha Grace Royal, Shoshik Amram, Lea Rozenstein-Tsalkovich, Dorit Trudler, Shani Blanga-Kanfi, Hagit Eldar-Finkelman, Jens Pahnke, Hanna Rosenmann, Dan Frenkel

    Published 2023-07-01
    Get full text
    Article
  8. 8
    GSK3β and β-Catenin Modulate Radiation Cytotoxicity in Pancreatic Cancer

    GSK3β and β-Catenin Modulate Radiation Cytotoxicity in Pancreatic Cancer by Richard L. Watson, Aaron C. Spalding, Steven P. Zielske, Meredith Morgan, Alex C. Kim, Guido T. Bommer, Hagit Eldar-Finkelman, Thomas Giordano, Eric R. Fearon, Gary D. Hammer, Theodore S. Lawrence, Edgar Ben-Josef

    Published 2010-05-01
    Get full text
    Article

Search Tools: